|
Author Question: Which of the following factors increase a patient's risk for obstructive sleep apnea? 1. Systemic ... (Read 19 times) |
The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.
By definition, when a medication is administered intravenously, its bioavailability is 100%.
Anti-aging claims should not ever be believed. There is no supplement, medication, or any other substance that has been proven to slow or stop the aging process.
Vaccines prevent between 2.5 and 4 million deaths every year.
The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.